Surgical Robot Developer NDR Medical Technology Raises US$5.75M Series A

NDR Medical Technology is looking to expand to China, Japan, and the U.S.

Singapore-based surgical robotics startup NDR Medical Technology has raised SG$8 million (US$5.75 million at current rates) in Series A financing, the company announced in a statement today.

The funding was led by Shanghai-headquartered medical device manufacturer MicroPort Scientific Corporation, the statement said. Singapore Government-owned deep tech investor SGInnovate and Kava Ventures (owned by Singapore-headquartered medtech distributor Transmedic Group) also pitched in.

SGInnovate had previously invested in NDR Medical Technology’s 2018 seed round for an undisclosed amount.

Further, this is MicroPort’s first equity investment in a Singaporean startup, indicating “the company’s growing interest in potential investment and collaboration opportunities within the region,” the statement noted.

NDR Medical Technology is a medical imaging startup founded in 2014 that builds surgical robots for use in automated surgical procedures.

According to the statement, the company will be utilizing the funds to expand into the U.S., process regulatory submissions in other markets, pursue clinical applications of its flagship Automated Needle Targeting (ANT) system, and build internal technical capabilities.

ANT works through artificial intelligence (AI) and medical image processing technology to identify internal damage and plan the insertion trajectory for invasive surgeries.

Chairman of MicroPort Urocare, Yiyun Que said in the statement, “The robotic-assisted ANT is a technology platform that has extensive applications. Considering the current trend for hierarchical healthcare system and AI-driven healthcare industry in China, we believe this technology will benefit more Chinese patients.”

The company has applied for the European Union’s Conformitè Europëenne (CE) certification and also has a clinical trial in the pipeline in Japan, the statement noted. It added that NDR Medical Technology has also set its sights on the Chinese market through a joint venture with MicroPort subsidiary MicroPort Urocare (Jiaxing).

The deal will help the company “accelerate our growth plans in Asia with greater assurance, fulfilling our vision of ensuring safer surgical procedures with better clinical outcome,” NDR Co-founder and CEO Alan Goh said in the statement.

Studies suggest that robot-assisted surgery (RAS) account for as much as 35% of all surgeries in the U.S., with around US$3 billion in yearly revenues that are expected to grow 15% year-on-year till 2022.

Further, the use of RAS for common surgeries grew four-fold between 2012 and 2018, from 1.8% to 15.1%, according to a study conducted in Michigan.

Valued at US$5.5 billion in 2018, some studies expect the market to see a compounded annual growth rate of 24.4% until 2025. Some others, however, suggest that the market may in fact shrink in size due to COVID-19 interrupting surgical schedules.

Header image by Eleventh Wave on Unsplash

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email
Sharon Lewis
Sharon is a Staff Writer at Jumpstart

RELATED POSTS

Squid Game

Squid Game and Its Lessons on Entrepreneurship

With the massive media buzz the South Korean series “Squid Game” has been getting, you would have to live under a rock to not know about it. It is so popular that a South Korean broadband firm has sued Netflix over the surge in network traffic.

What Is Biotechnology

What Is Biotechnology and How to Start a Biotech Company?

To say that Covid has been a biological nightmare for the world is an understatement. In a bid to wake up from it, companies and investors have turned their attention to science, medicine and innovation—or simply, biotechnology. With vaccines and cures becoming the need of the hour, BioTech rose like never before.

Netflix

Netflix Forays into Video Games with Night School Studio Acquisition

On September 28, 2021, streaming service Netflix announced its first game-related acquisition: Night School Studio. The studio is best known for its game “Oxenfree”, which is a supernatural teen thriller. In a bid to diversify its offerings, Netflix has also released five mobile-friendly video games in Europe (i.e. Spain, Italy and Poland).

Chloe NFT

Side-eyeing Chloe NFT Sold for US$76,377.50

In 2013, the then two-year-old Chloe Clems went viral as her hilarious side-eyeing expression made her into a beloved internet meme. In her meme avatar, little Chloe has ruled over the hearts of many a Twitter and Reddit enthusiast and has been dubbed the “Patron saint of Tumblr” by Buzzfeed.

What Are the Threats of Using Social Media

What Are the Threats of Using Social Media?

Social media has become a part of our everyday lives. As of September 2021, the largest social media platform Facebook has over 2.89 billion active users monthly. With people across the world relying heavily on social media platforms, it is expected that some of them would exploit these platforms for negative purposes as well.

Maker in China Fueling Hong Kong’s Startup Spirit

Maker in China: Fueling Hong Kong’s Startup Spirit

On September 17, 2021, the “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021 Grand Final was held in Guangzhou, China. MAD Gaze, a Cyberport incubatee specializing in augmented reality smart glasses, was declared the winner of the championship.